THE AMERICA ONE NEWS
Sep 14, 2025  |  
0
 | Remer,MN
Sponsor:  QWIKET 
Sponsor:  QWIKET 
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
back  
topic
Genevieve Glatsky


NextImg:Trump Administration Questions Colombia’s Anti-Drug Efforts and Weighs Cutting Aid

As the United States escalates its military campaign against drug traffickers near Venezuelan waters, destroying a vessel that officials said carried drugs, the Trump administration is simultaneously weighing whether to cut aid to Colombia, the world’s top cocaine producer.

For more than four decades, Colombia has been a cornerstone of U.S. counternarcotics strategy abroad, receiving billions in aid while providing intelligence on routes, networks and shipments.

Now that partnership is under threat.

At issue is a process called certification, an annual review with results expected to be announced on Monday about whether Colombia is doing enough to combat drugs.

While it is unknown what the Trump administration will do, decertification could have huge consequences, suspending hundreds of millions of dollars in aid, prompting sanctions and visa restrictions on government officials, and damaging one of Washington’s closest alliances in Latin America.

The U.S. State Department declined to comment on the administration’s plans.

But in recent months, Trump officials have been vocal in their criticism of Colombia for failing to reduce cultivation of coca, the raw material for cocaine.

“It is time to see results,” the U.S. State Department’s international narcotics agency posted on X. “Given record coca cultivation, there needs to be immediate and tangible progress on eradication.”


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.